Patients with rare diseases have high unmet medical needs.
Watch this video to learn:
- The challenges of rare disease drug development
- FDA mechanisms that encourage the development of treatments for rare diseases
- How Certara’s experts can help your rare disease drug program!
Ready to learn more about how our software and services supported the approval of over 100 orphan drugs, including over 90% of new novel drug approvals with orphan designation in the past 6 years by the US FDA?
